NCT02064465View on ClinicalTrials.gov

The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

March 15, 2014

Primary Completion Date

July 8, 2014

Study Completion Date

July 8, 2014

Conditions
Epilepsy
Interventions
DRUG

Lamotrigine Dispersible/Chewable tablet

Single dose of lamotrigine dispersible/chewable 100mg tablet at Day1

DRUG

Lamotrigine Compressed tablet

Single dose of lamotrigine compressed 100mg tablet at Day1

Trial Locations (1)

200030

GSK Investigational Site, Shanghai

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02064465 - The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg | Biotech Hunter | Biotech Hunter